Article thumbnail
Location of Repository

Statistical analysis of breast cancer data in a 3 yearsperiod (2016-2018) in Republic of North Macedonia andthe Eastern region

By Jihe Zhu, Blagica Arsovska and Kristina Kozovska

Abstract

Breast cancer is on the first place of malignant disease in women. By mortality it is4th most common and the incidence is constantly increasing in the world, in NorthMacedonia as well. Unfortunately, the exact number for cancer patients in NorthMacedonia is not known, but it is estimated that there are about 800 to 1 000 patientsper year. Stress is a serious risk factor and with most of the cancer patients in theanamnesis it is found that they were exposed to extreme stress. After the Bosnian warin the 90s, there was a sudden incidence of breast cancer. The rate of healing in theearly A1 stadium is from 98 to 100%. The problem in North Macedonia is that thescreening it’s not performed often, which causes the disease to be diagnosed in thelater stages. Most common is adenocarcinoma. In North Macedonia of all malignantneoplasms in women, breast cancer is first in mortality. Breast cancer mostly affectswomen aged 55 to 64 years at the level of the North Macedonia and the Easternregion. Compared to previous years, every year the number of breast cancer patientsis increasing, which means that the incidence of cancer is increasing. Work plansshould be directed to: health education of the population, education of women forproper and regular breast self-examination, education for regular screening for bothwomen and the general practitioners who should support and educate the populationon regular screening exams, as well as programs designed to support women who arebeing treated for breast cancer

Topics: Clinical medicine
Publisher: In n o v a t i v e J o u r n a l o f M e d i c a l a n d H e a l t h S c i e n c e
Year: 2019
OAI identifier: oai:eprints.ugd.edu.mk:22540

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.